Stockpicker Comparison Tool
Nothing here is comparable yet for these companies.
Revenue Growth
LMRI
7.82%
▲ 6.00%
BSX
7.53%
▼ -4.05%
Gross Margin
LMRI
10.90%
▲ 1.06%
BSX
70.71%
▲ 1.27%
Free Cash Flow
LMRI
$23.13M
▲ $25.51M
BSX
$1.28B
▲ $1.11B
Net Debt / EBITDA
LMRI
8.13
▲ 1.12
BSX
2.13
▲ 0.45
Operating Margin
LMRI
1.66%
▼ -0.13%
BSX
21.65%
▲ 1.04%
P/E Ratio
LMRI
—
BSX
19.51
▼ -0.68